Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amerimmune, Astrazeneca, Biophytis, Coherus, Exevir, Histogen, Innocare, Innovent, Junshi, Kyowa Kirin, Mei, Nrx, Senhwa, Telix, Tiziana Life Sciences, Transcenta, Zhaoke Ophthalmology.